Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element

Gene

Volumn 511, Issue 2, 2012, Pages 398-403

  Hou, Yanli ^a,b   Zhang, Shuping ^a   Wang, Lei ^a   Li, Junping ^a   Qu, Guangbo ^a   He, Jiuyang ^a   Rong, Haiqin ^b   Ji, Hong ^b   Liu, Sijin ^a  

^a RESEARCH CENTER FOR ECO ENVIRONMENTAL SCIENCES   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Estrogen; Estrogen response element; Hepcidin; Iron; Ovariectomy

Indexed keywords

ESTROGEN; HEMOGLOBIN; HEPCIDIN; IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ESTROGEN DEFICIENCY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENETIC TRANSFECTION; HOMEOSTASIS; HORMONAL REGULATION; IRON BLOOD LEVEL; IRON METABOLISM; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; OSTEOCLAST; OVARIECTOMY; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SPLEEN; TISSUE LEVEL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; ESTROGENS; FEMALE; HOMEOSTASIS; IRON; LIVER; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OVARIECTOMY; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; TRANSCRIPTION, GENETIC;

MUS;

EID: 84868193427     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.09.060     Document Type: Article

References (44)

1. Andriopoulos B., et al. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 2009, 41:482-487.
2. Bajic V.B., et al. Dragon ERE Finder version 2: a tool for accurate detection and analysis of estrogen response elements in vertebrate genomes. Nucleic Acids Res. 2003, 31:3605-3607.
3. Cote I., et al. Liver fat accumulation may be dissociated from adiposity gain in ovariectomized rats. Climacteric 2012, [Electronic publication ahead of print]. 10.3109/13697137.2011.637650.
4. Courselaud B., et al. C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism. J. Biol. Chem. 2002, 277:41163-41170.
5. Donovan A., et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005, 1:191-200.
6. Galesloot T.E., et al. Serum hepcidin: reference ranges and biochemical correlates in the general population. Blood 2011, 117:e218-e225.
7. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood 2003, 102:783-788.
8. Ganz T. Hepcidin in iron metabolism. Curr. Opin. Hematol. 2004, 11:251-254.
9. Ganz T. Hepcidin-a regulator of intestinal iron absorption and iron recycling by macrophages. Best Pract. Res. Clin. Haematol. 2005, 18:171-182.
10. Ganz T., Nemeth E. Hepcidin and disorders of iron metabolism. Annu. Rev. Med. 2011, 62:347-360.
11. Ganz T., Nemeth E. Hepcidin and iron homeostasis. Biochim. Biophys. Acta 2012, 1823:1434-1443.
12. Guggenbuhl P., et al. Bone mineral density in men with genetic hemochromatosis and HFE gene mutation. Osteoporos. Int. 2005, 16:1809-1814.
13. Guggenbuhl P., et al. Bone status in a mouse model of genetic hemochromatosis. Osteoporos. Int. 2011, 22:2313-2319.
14. Haidar R., Musallam K.M., Taher A.T. Bone disease and skeletal complications in patients with beta thalassemia major. Bone 2011, 48:425-432.
15. Hall J.M., Couse J.F., Korach K.S. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J. Biol. Chem. 2001, 276:36869-36872.
16. Ikeda Y., et al. Estrogen regulates hepcidin expression via GPR30-BMP6-dependent signaling in hepatocytes. PLoS One 2012, 7:e40465.
17. Ishii K.A., et al. Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat. Med. 2009, 15:259-266.
18. Iwasa T., et al. Effect of immune stress on body weight regulation is altered by ovariectomy in female rats. J. Reprod. Immunol. 2011, 91:41-47.
19. Jian J., Pelle E., Huang X. Iron and menopause: does increased iron affect the health of postmenopausal women?. Antioxid. Redox Signal. 2009, 11:2939-2943.
20. Jilka R.L., et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992, 257:88-91.
21. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001, 29:2905-2919.
22. Lehmann D.J., et al. Iron genes, iron load and risk of Alzheimer's disease. J. Med. Genet. 2006, 43:e52.
23. Liu G., Men P., Kenner G.H., Miller S.C. Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelation. Biometals 2006, 19:245-251.
24. Liu S., et al. The function of heme-regulated eIF2alpha kinase in murine iron homeostasis and macrophage maturation. J. Clin. Invest. 2007, 117:3296-3305.
25. Liu G., Men P., Kenner G.H., Miller S.C. Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in rats. Hemoglobin 2008, 32:181-190.
26. Liu S., Suragani R.N., Han A., Zhao W., Andrews N.C., Chen J.J. Deficiency of heme-regulated eIF2alpha kinase decreases hepcidin expression and splenic iron in HFE-/- mice. Haematologica 2008, 93:753-756.
27. Liu W., et al. CdSe quantum dot (QD)-induced morphological and functional impairments to liver in mice. PLoS One 2011, 6:e24406.
28. Mattace Raso G., et al. Ovariectomy and estrogen treatment modulate iron metabolism in rat adipose tissue. Biochem. Pharmacol. 2009, 78:1001-1007.
29. Messer J.G., Kilbarger A.K., Erikson K.M., Kipp D.E. Iron overload alters iron-regulatory genes and proteins, down-regulates osteoblastic phenotype, and is associated with apoptosis in fetal rat calvaria cultures. Bone 2009, 45:972-979.
30. Nemeth E., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 2004, 113:1271-1276.
31. Nemeth E., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306:2090-2093.
32. Pak M., Lopez M.A., Gabayan V., Ganz T., Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood 2006, 108:3730-3735.
33. Park C.H., Valore E.V., Waring A.J., Ganz T. Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J. Biol. Chem. 2001, 276:7806-7810.
34. Prossnitz E.R., Maggiolini M. Mechanisms of estrogen signaling and gene expression via GPR30. Mol. Cell. Endocrinol. 2009, 308:32-38.
35. Qu G., et al. Quantum dots impair macrophagic morphology and the ability of phagocytosis by inhibiting the Rho-associated kinase signaling. Nanoscale 2012, 4:2239-2244.
36. Ramos E., et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology 2011, 53:1333-1341.
37. Sottile V., Seuwen K., Kneissel M. Enhanced marrow adipogenesis and bone resorption in estrogen-deprived rats treated with the PPARgamma agonist BRL49653 (rosiglitazone). Calcif. Tissue Int. 2004, 75:329-337.
38. Thompson D.D., Simmons H.A., Pirie C.M., Ke H.Z. FDA guidelines and animal models for osteoporosis. Bone 1995, 17:125S-133S.
39. Valenti L., Varenna M., Fracanzani A.L., Rossi V., Fargion S., Sinigaglia L. Association between iron overload and osteoporosis in patients with hereditary hemochromatosis. Osteoporos. Int. 2009, 20:549-555.
40. Weinberg E.D. Iron loading: a risk factor for osteoporosis. Biometals 2006, 19:633-635.
41. Weinberg E.D. Role of iron in osteoporosis. Pediatr. Endocrinol. Rev. 2008, 6(Suppl. 1):81-85.
42. Yamasaki K., Hagiwara H. Excess iron inhibits osteoblast metabolism. Toxicol. Lett. 2009, 191:211-215.
43. Yang Q., Jian J., Abramson S.B., Huang X. Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. J. Bone Miner. Res. 2011, 26:1188-1196.
44. Yang Q., Jian J., Katz S., Abramson S.B., Huang X. 17beta-Estradiol inhibits iron hormone hepcidin through an estrogen responsive element half-site. Endocrinology 2012, 153:3170-3178.